Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke

Translational Stroke Research

Volumn 6, Issue 4, 2015, Pages 276-283

  Waje Andreassen, Ulrike ^a   Naess, Halvor ^a   Thomassen, Lars ^a,b   Maroy, Tove Helene ^a   Mazengia, Kibret Yimer ^a   Eide, Geir Egil ^a,b   Vedeler, Christian Alexander ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Carotid IMT; Fc gamma receptors; HbA1c; IL 10; Long term follow up; Young ischemic stroke

Indexed keywords

CHOLESTEROL; CREATININE; FC RECEPTOR; HEMOGLOBIN; HEMOGLOBIN A1C; HOMOCYSTEINE; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BLOOD SAMPLING; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDIMENTATION RATE; SEX DIFFERENCE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; COMPLICATION; ERYTHROCYTE SEDIMENTATION RATE; GENETIC POLYMORPHISM; GENETICS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SURVIVOR;

ADULT; BIOMARKERS; BLOOD SEDIMENTATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; FEMALE; HOMOCYSTEINE; HUMANS; INTERLEUKIN-10; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVORS;

EID: 84933679760     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0403-0     Document Type: Article

References (41)

1. Wang X, Liu X, Kishimoto C, Yuan Z. The role of fcgamma receptors in atherosclerosis. Exp Biol Med (Maywood). 2012;237(6):609–16.
2. Raaz D, Herrmann M, Ekici AB, Klinghammer L, Lausen B, Voll RE, et al. FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. Atherosclerosis. 2009;205(2):512–6.
3. Kim YS, Yoo JH, Lee BC. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the Fc gamma receptor IIA. Blood Coagul Fibrinolysis. 2009;20(5):353–7.
4. Karakas M, Hoffmann MM, Vollmert C, Rothenbacher D, Meisinger C, Winkelmann B, et al. Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations. BMC medical genetics 2009;1046
5. van der Meer IM, Witteman JC, Hofman A, Kluft C, de Maat MP. Genetic variation in fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study Thromb Haemost. 2004;92(6):1273–6.
6. Gavasso S, Nygard O, Pedersen ER, Aarseth JH, Bleie O, Myhr KM, et al. Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 2005;180(2):277–82.
7. Bjorkbacka H, Fredrikson GN, Nilsson J. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis. 2013;227(1):9–17.
8. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, Hansson GK, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med. 2003;9(1–2):10–7.
9. Sikka G, Miller KL, Steppan J, Pandey D, Jung SM, Fraser 3rd CD, et al. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp Gerontol. 2013;48(2):128–35.
10. Ambrosius W, Kazmierski R, Michalak S, Kozubski W. Anti-inflammatory cytokines in subclinical carotid atherosclerosis. Neurology. 2006;66(12):1946–8.
11. George J, Schwartzenberg S, Medvedovsky D, Jonas M, Charach G, Afek A, et al. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis. 2012;222(2):519–23.
12. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998;95(16):9465–70.
13. Crawley E, Isenberg D, Woo P, Kay R. Interleukin-10 promoter polymorphism and lupus nephritis: comment on the article by Mok et al. Arthritis Rheum. 1999;42(3):590–3.
14. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1–8.
15. Gallo P, Goncalves R, Mosser DM. The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett. 2010;133(2):70–7.
16. Waje-Andreassen U, Thomassen L, Jusufovic M, Power KN, Eide GE, Vedeler CA, et al. Ischaemic stroke at a young age is a serious event - final results of a population-based long-term follow-up in Western Norway. Eur J Neurol. 2013;20(5):818–23.
17. Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Meijer R, Vedeler CA. Ultrasound, atherosclerosis and stroke at a young age: a cross-sectional long-term follow-up in western Norway. Eur J Neurol 2008;15512–9
18. Johnson CJ, Kittner SJ, McCarter RJ, Sloan MA, Stern BJ, Buchholz D, et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke. 1995;26(1):46–51.
19. Naess H, Nyland HI, Thomassen L, Aarseth J, Nyland G, Myhr KM. Incidence and short-term outcome of cerebral infarction in young adults in western Norway. Stroke. 2002;33(8):2105–8.
20. Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Vedeler CA. Long-term mortality among young ischemic stroke patients in western Norway. Acta Neurol Scand. 2007;116(3):150–6.
21. Myhr KM, Vagnes KS, Maroy TH, Aarseth JH, Nyland HI, Vedeler CA. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. J Neurol Sci. 2002;202(1–2):93–7.
22. Temelkova-Kurktschiev T, Fischer S, Koehler C, Mennicken G, Henkel E, Hanefeld M. Intima-media thickness in healthy probands without risk factors for arteriosclerosis. Dtsch Med Wochenschr. 2001;126(8):193–7.
23. Aminbakhsh A, Mancini G. Carotid intima-media thickness measurements: what defines an abnormality? a systematic review. Clin Invest Med. 1999;22(4):149–57.
24. Joshi R, Khandelwal B, Joshi D, Gupta OP. Chlamydophila pneumoniae infection and cardiovascular disease. N Am J Med Sci. 2013;5(3):169–81.
25. Torkildsen O, Utsi E, Mellgren SI, Harbo HF, Vedeler CA, Myhr KM. Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology. 2005;115(3):416–21.
26. Torkildsen O, Utsi E, Harbo HF, Mellgren SI, Vedeler CA, Myhr KM. Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population. Scand J Immunol. 2005;62(1):71–4.
27. Masuda M, Amano K, Hong SY, Nishimura N, Fukui M, Yoshika M, et al. Soluble FcgammaRIIIa (Mphi) levels in plasma correlate with carotid maximum intima-media thickness (IMT) in subjects undergoing an annual medical checkup. Mol Med. 2008;14(7–8):436–42.
28. Schneider MP, Leusen JH, Herrmann M, Garlichs CD, Amann K, John S, et al. The Fcgamma receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia. Atherosclerosis. 2011;218(2):411–5.
29. Guilliams M, Bruhns P, Saeys Y, Hammad H, Lambrecht BN. The function of Fcgamma receptors in dendritic cells and macrophages. Nat Rev Immunol. 2014;14(2):94–108.
30. van der Pol W, van de Winkel JG. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 1998;48(3):222–32.
31. Harmon EY, Fronhofer 3rd V, Keller RS, Feustel PJ, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: apoe−/−FcgammaRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3(6):e001232.
32. Smith KG, Clatworthy MR. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol. 2010;10(5):328–43.
33. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol. 2006;19(1):50–6.
34. Xie G, Myint PK, Zaman MJ, Li Y, Zhao L, Shi P, et al. Relationship of serum interleukin-10 and its genetic variations with ischemic stroke in a Chinese general population. PLoS One. 2013;8(9):e74126.
35. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 2005;6(2):167–70.
36. Han X, Boisvert WA. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost. 2015;113(3):505–12.
37. Stensland-Bugge E, Bonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the tromso study. Atherosclerosis. 2001;154(2):437–48.
38. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation. 2001;104(23):2815–9.
39. Sinning C, Kieback A, Wild PS, Schnabel RB, Ojeda F, Appelbaum S, et al. Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clinical research in cardiology: official journal of the German Cardiac Society 2014.
40. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–67.
41. Gustavson K, von Soest T, Karevold E, Roysamb E. Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study. BMC Public Health 2012;12918